{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:19:58Z","timestamp":1784636398169,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.clml.2020.06.009","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T01:36:41Z","timestamp":1594777001000},"page":"e813-e820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prognostic Impact of Extramedullary Infiltration in Pediatric Low-risk Acute Myeloid Leukemia: A Retrospective Single-center Study Over 10 Years"],"prefix":"10.1016","volume":"20","author":[{"given":"Guan-hua","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-dong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-ping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-xi","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le-ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.06.009_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ctrv.2010.02.003","article-title":"Epidemiology of childhood cancer","volume":"36","author":"Kaatsch","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clml.2020.06.009_bib2","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1200\/JCO.2015.62.8289","article-title":"Collaborative efforts driving progress in pediatric acute myeloid leukemia","volume":"33","author":"Zwaan","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.06.009_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MOP.0000000000000855","article-title":"Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy","volume":"32","author":"Elgarten","year":"2020","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.clml.2020.06.009_bib4","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1200\/JCO.2009.24.8997","article-title":"Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12","volume":"28","author":"Harrison","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.06.009_bib5","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1200\/JCO.2009.25.6321","article-title":"Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98","volume":"28","author":"von Neuhoff","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.06.009_bib6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/leu.2008.313","article-title":"Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML","volume":"23","author":"Hollink","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2020.06.009_bib7","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/leu.2013.273","article-title":"The role of different genetic subtypes of CEBPA mutated AML","volume":"28","author":"Fasan","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2020.06.009_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pbc.20824","article-title":"Japanese Childhood AML Cooperative Study Group. Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia","volume":"48","author":"Kobayashi","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2020.06.009_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/sj.leu.2401971","article-title":"Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia","volume":"15","author":"Bisschop","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2020.06.009_bib10","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00043426-200310000-00004","article-title":"Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group","volume":"25","author":"Dusenbery","year":"2003","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.clml.2020.06.009_bib11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pbc.23201","article-title":"Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: a report from the Children's Oncology Group","volume":"58","author":"Johnston","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2020.06.009_bib12","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3109\/10428194.2014.953148","article-title":"Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia","volume":"56","author":"Rozovski","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.06.009_bib13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/pbc.22511","article-title":"The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children\u2019s Oncology Group study","volume":"55","author":"Johnston","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2020.06.009_bib14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jped.2015.08.008","article-title":"Acute myeloid leukemia: analysis of epidemiological profile and survival rate","volume":"92","author":"de Lima","year":"2016","journal-title":"J\u00a0Pediatr (Rio J)"},{"key":"10.1016\/j.clml.2020.06.009_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40272-014-0067-3","article-title":"Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia","volume":"16","author":"Faulk","year":"2014","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.clml.2020.06.009_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40272-016-0200-6","article-title":"Current management of childhood acute myeloid leukemia","volume":"19","author":"Rubnitz","year":"2017","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.clml.2020.06.009_bib17","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/j.clml.2018.03.013","article-title":"Myeloid sarcoma predicts superior outcome in pediatric AML; can cytogenetics solve the puzzle?","volume":"18","author":"Pramanik","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2020.06.009_bib18","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1038\/sj.leu.2403131","article-title":"Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution\u2019s experience","volume":"17","author":"Abbott","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2020.06.009_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26664","article-title":"Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups","volume":"64","author":"Creutzig","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2020.06.009_bib20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/10428194.2017.1361025","article-title":"KIT mutations correlate with adverse survival in children with core-binding factor acute myeloid leukemia","volume":"59","author":"Chen","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.06.009_bib21","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/cncr.23691","article-title":"Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia","volume":"113","author":"Tsimberidou","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.06.009_bib22","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00432-020-03128-7","article-title":"Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia","volume":"146","author":"Xu","year":"2020","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.clml.2020.06.009_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26612","article-title":"Central nervous system disease in pediatric acute myeloid leukemia: a report from the Children\u2019s Oncology Group","volume":"64","author":"Johnston","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2020.06.009_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MPH.0000000000001034","article-title":"Acute myeloid leukemia with central nervous system involvement in children: experience from the French Protocol Analysis ELAM02","volume":"40","author":"Felix","year":"2018","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.clml.2020.06.009_bib25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1200\/JCO.1997.15.2.466","article-title":"Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461","volume":"15","author":"Byrd","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.06.009_bib26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000205531","article-title":"High risk subgroup of acute myelomonocytic leukemia (AMML) with orbito-ocular granulocytic sarcoma (OOGS) in Turkish children. Retrospective analysis of clinical, hematological, ultrastructural and therapeutical findings of thirty-three OOGS","volume":"81","author":"Cavdar","year":"1989","journal-title":"Acta Haematol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020303074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020303074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:34:23Z","timestamp":1761870863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020303074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S2152265020303074"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.06.009","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Impact of Extramedullary Infiltration in Pediatric Low-risk Acute Myeloid Leukemia: A Retrospective Single-center Study Over 10 Years","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}